Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

October 23, 2023 0:39 (London Time)

Beam Therapeutics

Youtube Subscribe

...

Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.8947
MarketCap: 1,401,039,172.0
High: 18.34 Low: 16.95

Open: 17.76 Close: 17.69 Change: -0.07

Stop waiting time to find out about Beam Therapeutics: Our AI summarizes all info about it.

This document will help you to evaluate Beam Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Beam Therapeutics are: Beam, Therapeutics, Thursday, lay, NASDAQ, BEAM, say, …

Concept Map

...

Semantic Network

...

Stock Summary

Beam Therapeutics generated $20.12 million in revenue for the quarter. Beam Therapies generated $21.5 billion in revenue in the first quarter..

Today's Summary

Beam Therapeutics, a Cambridge biotech developing medicines that rely on gene editing, said Thursday that it will lay off about 100 employees, 20 percent of its workforce. Beam Therapies stock declined in premarket trading Thursday.

Today's News

Beam Therapeutics Inc. (NASDAQ: BEAM) said it plans to cut approximately 20% of its workforce, or around 100 jobs, as part of a corporate restructuring initiative. The first patient has now been dosed in a phase 1/2 trial. Beam Therapeutics, a Cambridge biotech developing medicines that rely on gene editing, said Thursday that it will lay off about 100 employees, 20 percent of its workforce, as it narrows its research focus to save money. Beam Therapeutics (NASDAQ: BEAM) is probably years away from making any money. The bull thesis is that it has a good shot at reaching its medium-term catalysts, which would then enable it to raise more capital and hopefully commercialize its most promising candidates. Beam Therapeutics stock declined by 2.5% in premarket trading Thursday. Beam Therapies stock declined in pre-market trading. The company disclosed Thursday that it is laying off its base editing programs and laying off 100 employees.

Stock Profile

" Russell Investments Group Ltd. increases stake in Beam Therapeutics; analysts provide mixed ratings and projections - best stocks. Beam Therapies generated $20.12 million in revenue for the quarter. Beam Therapeutics Inc. (US) job application for vp, business development at beam therapeutics. (NASDAQ:BEAM) Job Application for VP, Business Development at Beam Theraputics apply for this job. Beam Therapedutics has an analyst consensus of Moderate Buy, with a price target consensus of $49. Beam Therapeuticss stock price per share is $23.50 today (as of Aug 23, 2023) Beam Therapedutics stock market cap is $1.86B. If you had invested in Beam Theraputics stock at $18.75 your return over the last 3 years would have been 25.33%."

Keywords

The game is changing. There is a new strategy to evaluate Beam Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Beam Therapeutics are: Beam, Therapeutics, Thursday, lay, NASDAQ, BEAM, say, and the most common words in the summary are: beam, therapeutic, stock, market, news, company, share, . One of the sentences in the summary was: Beam Therapies stock declined in premarket trading Thursday.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #beam #therapeutic #stock #market #news #company #share.

Read more →

Related Results

...
November 30, 2023 0:19 (London Time)

Beam Therapeutics

Beam Therapeutics (BEAM) has 13.826M shares short, which is 21.51% of float and 8.12 times average daily trading volume. The company is laying off a…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.7346
MarketCap: 2,426,375,776.0
High: 30.21 Low: 28.42

Open: 30.14 Close: 28.59 Change: -1.55

Read more →
...
September 15, 2023 0:57 (London Time)

Beam Therapeutics

Beam Therapeutics (BEAM) reported earnings of -$1.08 per share, beating the Zacks Consensus Estimate of $-1.38 per share. Beam Therapies trades on t…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.836
MarketCap: 1,982,363,510.0
High: 25.46 Low: 24.88

Open: 25.17 Close: 25.14 Change: -0.03

Read more →
...
October 23, 2023 0:39 (London Time)

Beam Therapeutics

Beam Therapeutics, a Cambridge biotech developing medicines that rely on gene editing, said Thursday that it will lay off about 100 employees, 20 pe…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.8947
MarketCap: 1,401,039,172.0
High: 18.34 Low: 16.95

Open: 17.76 Close: 17.69 Change: -0.07

Read more →
...
August 24, 2023 18:36 (London Time)

Beam Therapeutics

Beam Therapeutics generated $20.12 million in revenue for the quarter. Russell Investments Group Ltd. increases stake.
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.7506
MarketCap: 1,861,188,273.0
High: 23.46 Low: 22.7

Open: 23.46 Close: 23.19 Change: -0.27

Read more →